Table 4.

VTE incidence by Khorana score

	1, low risk (n=260)	≥2, high risk (n=212)
Overall VTE incidence rate during entire follow-up period, cases per 100 PY	16.0	22.4
PE	10.5	14.2
DVT, lower extremity	7.0	9.8
DVT, upper extremity	1.4	4.3
Other	1.4	1.4
Overall VTE incidence rate or anticoagulant within 3 days of venous ultrasound, cases per 100 PY	16.7	25.4
Overall VTE incidence rate (first event of PE, DVT, or other) by baseline use of oral anticoagulant), cases per 100 PY
Yes	23.1	17.4
No	15.3	22.9
Overall VTE cumulative incidence during 6-month follow-up period, cases per 100 patients	10.8	15.1
PE	6.5	9.4
DVT, lower extremity	6.2	7.6
DVT, upper extremity	1.2	3.8
Other	1.2	1.4

DVT, deep vein thrombosis; ICI, immune checkpoint inhibitor; PE, pulmonary embolism; PY, patient-years; VTE, venous thromboembolism.